scholarly journals Antipsychotic drugs – information and choice: a patient survey

2005 ◽  
Vol 29 (10) ◽  
pp. 369-371 ◽  
Author(s):  
Banke Olofinjana ◽  
David Taylor
Keyword(s):  
Atypical Antipsychotic ◽  
Antipsychotic Medication ◽  
Antipsychotic Drugs ◽  
Clinical Excellence ◽  
Information Provision ◽  
Patient Survey ◽  
Patient Choice ◽  
Clinical Implications ◽  
Atypical Antipsychotic Drugs ◽  
Nice Guidance

Aims and MethodThe National Institute for Clinical Excellence (NICE) has issued guidance on the use of atypical antipsychotic drugs and recommended that patients be involved in a discussion about the antipsychotic prescribed to them. We undertook a study to evaluate information provision and patient choice subsequent to the publication of this guidance. Patients were recruited from the South London and Maudsley Trust and interviewed. Case notes were examined for documentation of informed discussions.ResultsThirty patients were interviewed, of whom 15 claimed to have received no information. Twenty-seven patients felt that they had had no choice in regard to antipsychotic prescribed. None of the patients had documentation in their notes to suggest that they were involved in informed discussions about the antipsychotic they were prescribed.Clinical ImplicationsPatients were not involved in decisions regarding the antipsychotic medication prescribed. Practice did not follow the NICE guidance.

The spectrum of subjective effects of antipsychotic medication

2003 ◽  
Vol 15 (5) ◽  
pp. 274-279 ◽  
Author(s):  
Hugo A Wolters ◽  
Rikus Knegtering ◽  
Durk Wiersma ◽  
Robert J van den Bosch
Keyword(s):  
Atypical Antipsychotic ◽  
Antipsychotic Medication ◽  
Antipsychotic Drugs ◽  
Subjective Effects ◽  
Interview Data ◽  
Subjective Experiences ◽  
Atypical Antipsychotic Drugs ◽  
Psychological Domain

Background:This study examined the spectrum of subjective experiences which patients attribute to the use of antipsychotic medication.Methods:We collected interview data and answers to structured questions based on a comprehensive checklist in 77 patients using various types of classical or atypical antipsychotic drugs.Results:The responses of the patients could be categorized into psychological and somatic domains. The psychological domain could be subdivided into emotional, cognitive and sociability domains. The somatic set could be subdivided into activation and physiological domains.Conclusions:Our data reveal that the same effects may be experienced in either a positive or a negative way by different patients. We conclude that existing scales for measuring subjective effects of antipsychotic medication are incomplete.

scholarly journals Improving adherence to NICE guidance for bipolar illness: valproate use in women of childbearing potential

2011 ◽  
Vol 35 (2) ◽  
pp. 63-67 ◽  
Author(s):  
Shubhra Mace ◽  
David Taylor
Keyword(s):  
Contraceptive Use ◽  
Clinical Excellence ◽  
Information Provision ◽  
Clinical Implications ◽  
Intervention Programme ◽  
Childbearing Potential ◽  
Bipolar Illness ◽  
Nice Guidance ◽  
Improvement Programme ◽  
The Impact

Aims and methodTo assess the impact in the South London and Maudsley NHS Foundation Trust of a 20-month quality improvement programme on adherence with National Institute for Health and Clinical Excellence (NICE) recommendations for the use of valproate for bipolar illness in women of childbearing potential.ResultsSignificant improvement was noted between baseline and final audit in rates of information provision (10% v. 63%, P < 0.0001), contraceptive use (15% v. 38%, P = 0.0003) and folate prescription (3% v. 35%, P < 0.0001).Clinical implicationsAdherence to guidance can be usefully improved by a sustained intervention programme.

scholarly journals H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs

2003 ◽  
Vol 28 (3) ◽  
pp. 519-526 ◽  
Author(s):  
Wesley K Kroeze ◽  
Sandra J Hufeisen ◽  
Beth A Popadak ◽  
Sean M Renock ◽  
SeAnna Steinberg ◽  
...  
Keyword(s):  
Weight Gain ◽  
Atypical Antipsychotic ◽  
Antipsychotic Drugs ◽  
Histamine Receptor ◽  
Short Term ◽  
Receptor Affinity ◽  
Atypical Antipsychotic Drugs

New Disulfide Route to 3-(1-Piperazinyl)-1,2-benzisothiazole. Nucleus for Atypical Antipsychotic Drugs

1999 ◽  
Vol 3 (2) ◽  
pp. 126-130 ◽  
Author(s):  
Stanley W. Walinsky ◽  
Darrell E. Fox ◽  
John F. Lambert ◽  
Terry G. Sinay
Keyword(s):  
Atypical Antipsychotic ◽  
Antipsychotic Drugs ◽  
Atypical Antipsychotic Drugs
Sign in / Sign up

Export Citation Format

Share Document